To this end, the amylin and glucagon-like peptide-1 (GLP-1) hormonal systems have been independently identified as promising targets for pharmacotherapy intervention 6,7,8,9,10,11
They slow the disease rather than restoring lost function, and the evidence is specific to people who already have early Alzheimers with confirmed amyloid, though secondary prevention trials are now testing whether clearing amyloid in cognitively normal but amyloid-positive people can delay the disease
Risk of infection : If not done hygienically, injections can cause infections
Furthermore, it reduces the risk of bone fracture and enhances cognition
I take 5 mg of GHK-Cu as part of a KLOW stack in 1ml total volume